World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
23717
World Ranking
12893
National Ranking
401

Yi Ba publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Yi Ba sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 260 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Yi Ba D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Yi Ba sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Yi Ba is affiliated with the Beijing Institute of Genomics in China and has an extensive record of publications predominantly in the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans significant contributions to oncology, pulmonary and respiratory medicine, molecular biology, surgery, and cancer research.

The scientist's work focuses on several main topics, including:

  • Gastric Cancer Management and Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Treatments and Mutations
  • Esophageal Cancer Research and Treatment
  • Gastrointestinal Tumor Research and Treatment
  • Pancreatic and Hepatic Oncology Research

Yi Ba's frequent publication venues emphasize oncology and cancer research, with multiple papers appearing in:

  • Journal of Clinical Oncology
  • Research Square
  • Cancer Biology and Medicine
  • Cancer Research
  • Annals of Oncology

The scientist has collaborated often with several coauthors, including Ting Deng, Yuxian Bai, Hongli Li, Haiyang Zhang, and Yuchong Yang.

Significant recent publications include:

  • "CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer," 2020, Molecular Cancer
  • "Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma," 2021, JAMA
  • "Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study," 2020, The Lancet Oncology
  • "Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer," 2020, Molecular Oncology
  • "Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer," 2022, Advanced Science

Yi Ba's research contributes extensively to understanding cancer mechanisms such as chemo-resistance and ferroptosis, as well as clinical outcomes related to immunotherapy and chemotherapy across several types of cancer. Their work intersects molecular oncology and clinical interventions, addressing complex issues in gastrointestinal and thoracic oncology.

Best Publications

  • Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

    Xi Chen;Yi Ba;Lijia Ma;Lijia Ma;Xing Cai

  • Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration

    Yujing Zhang;Danqing Liu;Xi Chen;Jing Li

  • Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA

    Lin Zhang;Dongxia Hou;Xi Chen;Donghai Li

  • Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

    Jin Li;Shukui Qin;Jianming Xu;Jianping Xiong

  • CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.

    Haiyang Zhang;Ting Deng;Rui Liu;Tao Ning

  • Role of miR-143 targeting KRAS in colorectal tumorigenesis

    X. Chen;X. Guo;H. Zhang;H. Zhang;Y. Xiang

  • A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis

    Rui Liu;Chunni Zhang;Zhibin Hu;Gou Li;Gou Li

  • Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial

    Huiyan Luo;Huiyan Luo;Jin Lu;Yuxian Bai;Teng Mao

  • Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.

    Jing Huang;Jianming Xu;Yun Chen;Wu Zhuang

  • Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer

    Rui Liu;Rui Liu;Xi Chen;Xi Chen;Yiqi Du;Weiyan Yao

  • Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

    Haiyang Zhang;Ting Deng;Rui Liu;Ming Bai

  • Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.

    Xinyi Wang;Haiyang Zhang;Haiou Yang;Ming Bai

  • Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432.

    F. Wang;X.L. Wei;F.H. Wang;N. Xu

  • Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

    Xi Chen;Zhibin Hu;Wenjing Wang;Yi Ba

  • Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7.

    Haiyang Zhang;Ting Deng;Shaohua Ge;Ying Liu

  • Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway.

    Haiyang Zhang;Lei Zhu;Ming Bai;Ying Liu

  • Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer

    Xinyi Wang;Haiyang Zhang;Ming Bai;Tao Ning

  • Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells.

    Haiou Yang;Haiyang Zhang;Shaohua Ge;Tao Ning

  • miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer

    Xin Yan;Xin Yan;Xi Chen;Hongwei Liang;Ting Deng

  • Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

    Zhong Zhen Guan;Jian Ming Xu;Rong Cheng Luo;Feng Yi Feng

Frequent Co-Authors

Chen-Yu Zhang
Chen-Yu Zhang Nanjing University
Ke Zen
Ke Zen Nanjing University
Xi Chen
Xi Chen Nanjing University
Rui-Hua Xu
Rui-Hua Xu Sun Yat-sen University
Yongqian Shu
Yongqian Shu Nanjing Medical University
Jianming Xu
Jianming Xu Zhejiang University
Li Zhang
Li Zhang Sun Yat-sen University
Jifeng Feng
Jifeng Feng Nanjing Medical University
Zhibin Hu
Zhibin Hu Nanjing Medical University
Satoshi Morita
Satoshi Morita Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA can open numerous doors to rewarding health science careers. For those interested in the intersection of healthcare, technology, and data, medical coding is a promising path. The medical.coding salary remains competitive, making it an attractive option for recent graduates.

Medical billing and coding jobs are in high demand due to a growing need for accurate health information management. Learn more about job trends and market needs by reading is medical billing and coding in demand.

If you’re considering a fast, affordable route to start or advance your health information career, review the affordable online him programs now widely available.

For students interested in applying biochemistry or biology expertise to health and wellness, an online nutrition masters may lead to careers in dietetics, research, or public health.

These related degrees and pathways highlight how online study can support your growth in biology, biochemistry, and allied health fields.

Best Scientists Citing Yi Ba

Trending Scientists

Recently Published Articles